🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Alcoholic Cirrhosis

Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement NCT06814990NA1 site📍 Jena Stephanie Gräger · Tests: Cardiac MRI, Blood samples, Echocardiography Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States NCT05832229Phase 213 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Institute of Diabetes and Digestive and Kidney Dis… · Tests: Rosuvastatin An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis NCT07169526n/a1 site📍 Hanover Hannover Medical School A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH NCT06419374Phase 3330 sites📍 Birmingham📍 Homewood📍 Chandler Hoffmann-La Roche · Tests: Pegozafermin, Placebo Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD NCT05644717Phase 41 site📍 Peshawar Getz Pharma · Tests: Ertugliflozin 5 mg, 15mg Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease NCT05309863n/a3 sites📍 Ghent📍 Ghent📍 De Haan University Hospital, Ghent · Tests: Lifestyle management Efficacy of Simvastatin in Alcoholic Liver Fibrosis NCT04971577Phase 2, Phase 31 site📍 Barcelona Anna Cruceta · Tests: Simvastatin 40mg Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis NCT04689152Phase 315 sites📍 Ansan📍 Bucheon-si📍 Cheonan Pharmicell Co., Ltd. · Tests: Cellgram-LC, Best Supportive Care (BSC) The European NAFLD Registry NCT04442334n/a37 sites📍 Antwerp📍 Helsinki📍 Angers Newcastle University A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients NCT03472157NA1 site📍 Lille University Hospital, Lille · Tests: Lifestyle therapy, Bariatric surgery Establishment of NAFLD Cohort and Development of Fibrosis Markers NCT02206841n/a1 site📍 Seoul Seoul National University Boramae Hospital · Tests: Liver biopsy, ARFI, SWE, Transient elastography Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease NCT04106518n/a9 sites📍 Angers📍 Besançon📍 Bondy University Hospital, Lille Liver Damage and Cardiometabolic Disorders in NAFLD NCT04036357n/a1 site📍 Rome University of Roma La Sapienza Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers NCT03308916NA1 site📍 Odense Maja Thiele · Tests: transient elastography, Enhanced liver fibrosis test, Indirect serum markers of liver fibrosis, Direct serum markers of… Faecal Microbiota Transplantation for Liver Cirrhosis NCT04932577Phase 2, Phase 31 site📍 Aarhus University of Aarhus · Tests: Faecal microbiota transplantation, Placebo Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients NCT06814600n/a1 site📍 Brussels Centre Hospitalier Universitaire Saint Pierre · Tests: Transient elastometry Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) NCT07631637Phase 216 sites📍 Tucson📍 Tucson📍 Tucson Regeneron Pharmaceuticals · Tests: ALN-CIDEB, Placebo PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies NCT04371042n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome NCT06519162n/a1 site📍 Daejeon Chungnam National University Hospital InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis NCT06461208Phase 323 sites📍 Basildon📍 Bournemouth📍 Bristol King's College London · Tests: Encapsulated FMT, Placebo Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital Cardiac Dysfunction in Patients with Fatty Liver Disease NCT06386094n/a1 site📍 Chandigarh Post Graduate Institute of Medical Education and Research, … · Tests: Echocardiographic assessment Optimized Remission in Alcohol-related Liver Cirrhosis NCT06866496NA1 site📍 Hvidovre Copenhagen University Hospital, Hvidovre · Tests: Motivational interviews, Standard of Care (SOC) Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans NCT05526144Phase 21 site📍 Columbia VA Office of Research and Development · Tests: Synthroid, Placebo The Liver Care Trial NCT05855031NA2 sites📍 Køge📍 Roskilde Zealand University Hospital · Tests: Transient Elastography A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes NCT07241195n/a1 site📍 Hangzhou The Affiliated Hospital of Hangzhou Normal University Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) NCT06599918Phase 21 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Nicotinamide, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy